JP2020532521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532521A5 JP2020532521A5 JP2020512022A JP2020512022A JP2020532521A5 JP 2020532521 A5 JP2020532521 A5 JP 2020532521A5 JP 2020512022 A JP2020512022 A JP 2020512022A JP 2020512022 A JP2020512022 A JP 2020512022A JP 2020532521 A5 JP2020532521 A5 JP 2020532521A5
- Authority
- JP
- Japan
- Prior art keywords
- nitric oxide
- group
- oxide according
- ino
- pulmonary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 34
- 208000002815 pulmonary hypertension Diseases 0.000 claims 5
- 230000002861 ventricular Effects 0.000 claims 4
- 210000005240 left ventricle Anatomy 0.000 claims 3
- 210000005241 right ventricle Anatomy 0.000 claims 3
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 2
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- 230000004872 arterial blood pressure Effects 0.000 claims 1
- 230000008602 contraction Effects 0.000 claims 1
- 230000003205 diastolic effect Effects 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 230000007954 hypoxia Effects 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 230000009424 thromboembolic effect Effects 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023080033A JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2024209997A JP2025029093A (ja) | 2017-08-30 | 2024-12-03 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762552022P | 2017-08-30 | 2017-08-30 | |
| US62/552,022 | 2017-08-30 | ||
| US201762611325P | 2017-12-28 | 2017-12-28 | |
| US62/611,325 | 2017-12-28 | ||
| PCT/US2018/048524 WO2019046413A1 (en) | 2017-08-30 | 2018-08-29 | USE OF INHALED NITRIC OXIDE FOR ENHANCED RIGHT AND / OR LEFT VENTRICULAR FUNCTION |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080033A Division JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020532521A JP2020532521A (ja) | 2020-11-12 |
| JP2020532521A5 true JP2020532521A5 (https=) | 2021-10-07 |
Family
ID=65526008
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512022A Pending JP2020532521A (ja) | 2017-08-30 | 2018-08-29 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2020512411A Pending JP2020532531A (ja) | 2017-08-30 | 2018-08-29 | 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用 |
| JP2023080033A Pending JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2024209997A Pending JP2025029093A (ja) | 2017-08-30 | 2024-12-03 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512411A Pending JP2020532531A (ja) | 2017-08-30 | 2018-08-29 | 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用 |
| JP2023080033A Pending JP2023100985A (ja) | 2017-08-30 | 2023-05-15 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
| JP2024209997A Pending JP2025029093A (ja) | 2017-08-30 | 2024-12-03 | 右室及び／又は左室機能の改善のための吸入用一酸化窒素の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20200360647A1 (https=) |
| EP (2) | EP3675840A4 (https=) |
| JP (4) | JP2020532521A (https=) |
| KR (1) | KR20200083443A (https=) |
| CN (3) | CN120131593A (https=) |
| AU (2) | AU2018324004A1 (https=) |
| BR (1) | BR112020004205A2 (https=) |
| CA (4) | CA3073948A1 (https=) |
| IL (2) | IL272314A (https=) |
| MX (2) | MX2020002194A (https=) |
| PH (1) | PH12020500197A1 (https=) |
| SG (1) | SG11202000893QA (https=) |
| TW (3) | TWI887195B (https=) |
| WO (2) | WO2019046415A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2717525C1 (ru) | 2017-02-27 | 2020-03-23 | Сёрд Поул, Инк. | Системы и способы получения оксида азота |
| US10328228B2 (en) | 2017-02-27 | 2019-06-25 | Third Pole, Inc. | Systems and methods for ambulatory generation of nitric oxide |
| MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
| MX2021008418A (es) * | 2019-01-14 | 2021-08-19 | Bellerophon Therapeutics | Terapias de farmaco de combinacion de inhibidores de fosfodiesterasa tipo 5 (pde-5) y oxido nitrico inhalado. |
| EP3969416A4 (en) | 2019-05-15 | 2023-11-01 | Third Pole, Inc. | SYSTEMS AND DEVICES FOR GENERATING NITROGEN OXIDE |
| EP3969016A4 (en) | 2019-05-15 | 2023-08-16 | Third Pole, Inc. | ARCHITECTURES FOR THE PRODUCTION OF NITROUS OXIDE |
| JP2022533628A (ja) | 2019-05-15 | 2022-07-25 | サード ポール，インコーポレイテッド | 一酸化窒素生成用電極 |
| US11691879B2 (en) | 2020-01-11 | 2023-07-04 | Third Pole, Inc. | Systems and methods for nitric oxide generation with humidity control |
| US12239460B2 (en) * | 2020-05-06 | 2025-03-04 | Janssen Pharmaceuticals, Inc. | Controlling operation of drug administration devices using surgical hubs |
| CA3180709A1 (en) * | 2020-05-29 | 2021-12-02 | Martin DEKKER | Method for pulsatile delivery of a gaseous drug |
| US20210395905A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
| WO2022082072A1 (en) | 2020-10-16 | 2022-04-21 | Third Pole, Inc. | Nitric oxide generation process controls |
| US11975139B2 (en) | 2021-09-23 | 2024-05-07 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
| US12569628B2 (en) | 2022-04-14 | 2026-03-10 | Third Pole, Inc. | Delivery of medicinal gas in a liquid medium |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2101777B1 (en) * | 2006-12-12 | 2015-05-20 | Gilead Sciences, Inc. | Composition for treating a pulmonary hypertension |
| US7943667B2 (en) * | 2007-10-11 | 2011-05-17 | Duke University | Potentiating the effect of compound comprising nitric oxide |
| CN101969974A (zh) * | 2008-01-31 | 2011-02-09 | 范德比尔特大学 | 对于肺部病症的治疗 |
| CA2671029A1 (en) * | 2009-06-30 | 2010-12-30 | James S. Baldassarre | Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
| US20120093948A1 (en) * | 2009-11-20 | 2012-04-19 | Fine David H | Nitric Oxide Treatments |
| AU2011336358B2 (en) * | 2010-12-03 | 2016-09-29 | VERO Biotech LLC. | Nitric oxide treatments |
| JP6215314B2 (ja) * | 2012-05-31 | 2017-10-18 | イノ セラピューティクス エルエルシー | 一酸化窒素を動脈血または動脈血化血（ａｒｔｅｒｉａｌｉｚｅｄｂｌｏｏｄ）に投与する方法 |
| KR102357044B1 (ko) * | 2012-12-04 | 2022-02-08 | 말린크로트 파마슈티칼스 아일랜드 리미티드 | 일산화질소 전달 동안 투약량의 희석을 최소화하기 위한 캐뉼라 |
| US9795756B2 (en) * | 2012-12-04 | 2017-10-24 | Mallinckrodt Hospital Products IP Limited | Cannula for minimizing dilution of dosing during nitric oxide delivery |
| CA2936490C (en) * | 2014-01-10 | 2022-10-04 | Ino Therapeutics Llc | Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children |
| CN106572813B (zh) * | 2014-03-28 | 2020-07-17 | 沙普医疗系统公司 | 用于量化慢性疾病的多种可能形式对被报告呼吸困难的患者的贡献的可能性的模式识别系统 |
| EP3386574A4 (en) * | 2015-12-11 | 2019-07-17 | Vero Biotech LLC | METHOD AND APPARATUS FOR GAS ADMINISTRATION COMPRISING NITRIC OXIDE FOR TREATING FIBROSIS |
| CA3009986A1 (en) * | 2015-12-28 | 2017-07-06 | Vero Biotech LLC | Method and apparatus for administering nitric oxide with supplemental drugs |
| EP3413899A4 (en) * | 2016-02-12 | 2019-10-02 | Mallinckrodt Hospital Products IP Limited | USE AND MONITORING OF INHALED STAIN OXIDE WITH LEFT-VENTRICULAR SUPPORT DEVICES |
-
2018
- 2018-08-29 CA CA3073948A patent/CA3073948A1/en active Pending
- 2018-08-29 KR KR1020207008998A patent/KR20200083443A/ko not_active Ceased
- 2018-08-29 US US16/643,167 patent/US20200360647A1/en not_active Abandoned
- 2018-08-29 SG SG11202000893QA patent/SG11202000893QA/en unknown
- 2018-08-29 BR BR112020004205-6A patent/BR112020004205A2/pt unknown
- 2018-08-29 AU AU2018324004A patent/AU2018324004A1/en not_active Abandoned
- 2018-08-29 EP EP18851496.2A patent/EP3675840A4/en not_active Withdrawn
- 2018-08-29 JP JP2020512022A patent/JP2020532521A/ja active Pending
- 2018-08-29 CN CN202411395162.XA patent/CN120131593A/zh active Pending
- 2018-08-29 CN CN201880055684.1A patent/CN111315283A/zh active Pending
- 2018-08-29 WO PCT/US2018/048526 patent/WO2019046415A1/en not_active Ceased
- 2018-08-29 AU AU2018323547A patent/AU2018323547A1/en not_active Abandoned
- 2018-08-29 CA CA3266320A patent/CA3266320A1/en active Pending
- 2018-08-29 CN CN201880055696.4A patent/CN111372577A/zh active Pending
- 2018-08-29 CA CA3266267A patent/CA3266267A1/en active Pending
- 2018-08-29 MX MX2020002194A patent/MX2020002194A/es unknown
- 2018-08-29 US US16/643,198 patent/US20200188319A1/en not_active Abandoned
- 2018-08-29 EP EP18852330.2A patent/EP3675719A4/en not_active Withdrawn
- 2018-08-29 CA CA3073949A patent/CA3073949A1/en active Pending
- 2018-08-29 WO PCT/US2018/048524 patent/WO2019046413A1/en not_active Ceased
- 2018-08-29 JP JP2020512411A patent/JP2020532531A/ja active Pending
- 2018-08-30 TW TW107130330A patent/TWI887195B/zh active
- 2018-08-30 TW TW107130307A patent/TW201919590A/zh unknown
- 2018-08-30 TW TW112149987A patent/TW202416939A/zh unknown
-
2020
- 2020-01-27 PH PH12020500197A patent/PH12020500197A1/en unknown
- 2020-01-28 IL IL272314A patent/IL272314A/en unknown
- 2020-01-28 IL IL272308A patent/IL272308A/en unknown
- 2020-02-26 MX MX2025004666A patent/MX2025004666A/es unknown
-
2023
- 2023-05-15 JP JP2023080033A patent/JP2023100985A/ja active Pending
-
2024
- 2024-12-03 JP JP2024209997A patent/JP2025029093A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020532521A5 (https=) | ||
| JP2020532531A5 (https=) | ||
| JP2020073566A5 (https=) | ||
| JP2021193148A5 (https=) | ||
| JP2020518599A5 (https=) | ||
| Setten et al. | Prone position in patients with acute respiratory distress syndrome | |
| WO2009033665A3 (en) | Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent | |
| JP2015110631A5 (https=) | ||
| JP2019206562A5 (https=) | ||
| US20210283049A1 (en) | Intravenous sotalol hydrochloride loading and maintenance for cardiac surgery patients | |
| WO2018121457A1 (zh) | 一种多肽在预防或治疗心肌缺血再灌注损伤相关疾病中的药物应用 | |
| RU2010113994A (ru) | Применение панкреатического полипептида человека в качестве терапевтического средства | |
| JP2022062153A5 (https=) | ||
| Misumi et al. | Constrictive pericarditis following mRNA COVID-19 vaccination in a patient with systemic sclerosis | |
| Jensen et al. | Electroshock for atrial flutter and atrial fibrillation: follow-up studies on 50 patients | |
| JP2019507174A (ja) | 心血管疾患におけるリラグルチド | |
| JPWO2020033768A5 (https=) | ||
| Santi et al. | Atrial fibrillation in a child with COVID-19 infection | |
| Aggarwal et al. | Glucocorticoids for treating paediatric pulmonary hypertension: a novel use for a common medication | |
| Sezai et al. | Early and long-term outcomes in Japanese patients aged 80 years or older undergoing conventional aortic valve replacement | |
| Cokkinos et al. | Idiopathic pulmonary arterial hypertension in a young patient with the Cohen syndrome | |
| JP2021527130A5 (https=) | ||
| CN107617101A (zh) | 含唑来膦酸和白细胞介素2的药物组合及其应用 | |
| Flores et al. | Rheumatoid Arthritis with severe Aortic lnsufficiency and Prolapse of the Mitral Valve | |
| Minic et al. | 217* A multi-cycle open label study of nebulized liposomal amikacin (Arikace (tm)) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection |